4.7 Article

Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Omega-3 fatty acids and protein metabolism: enhancement of anabolic interventions for sarcopenia

Filippo Giorgio Di Girolamo et al.

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2014)

Article Oncology

Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

Maximilien Barret et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2014)

Article Geriatrics & Gerontology

Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?

David R. Fogelman et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)

Editorial Material Geriatrics & Gerontology

Are we closer to having drugs to treat muscle wasting disease?

John E. Morley et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)

Review Geriatrics & Gerontology

An overview of amines as nutritional supplements to counteract cancer cachexia

Patricia Lopes de Campos-Ferraz et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)

Review Geriatrics & Gerontology

Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management

Hidetaka Wakabayashi et al.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2014)

Article Gastroenterology & Hepatology

Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

Peter Peng et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2012)

Article Gastroenterology & Hepatology

Pancreaticoduodenectomy with vascular resection: Margin status and survival duration

JF Tseng et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2004)

Article Gastroenterology & Hepatology

Neoadjuvant treatment of advanced stage esophageal adenocarcinoma increases survival

TN Walsh et al.

DISEASES OF THE ESOPHAGUS (2002)